ZIC5 was expressed in > 1% of tumor cells in 15/29 (52%) of evaluable GS 4 + 3 = 7 patients and 55/135 (41%) of GS 3 + 4 = 7 patients (p = 0.28). The gene discussed is ZIC5; the disease is neoplasm.